EBMcalc Logo
   INTRO    EQUATIONS    CRITERIA    DECISION TREES    CONVERTERS    SPECIALTIES    OPTIMIZERS    REFS    SEARCH    PRESS ROOM   
 
  International Prognostic Index for Non-Hodgkin Lymphoma

 
The EBMcalc module International Prognostic Index for Non-Hodgkin Lymphoma is available in EBMcalc Complete Edition.
 

 
This calculator evaluates the following Clinical Criteria:
 
References
  1. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993 Sep 30;329(14):987-94. PMID: 8141877 PubMed Logo
  2. Ziepert M, Hasenclever D, Kuhnt E, et. al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010 May 10;28(14):2373-80. Epub 2010 Apr 12. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779. PMID: 20385988 PubMed Logo
  3. Oken MM, Creech RH, Tormey DC, et. al., Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55. PMID: 7165009 PubMed Logo

 

 
Legal Notices and Disclaimer

 
All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer.
 
EBMcalc is Copyright © 1998-2017 Foundation Internet    [Build 254410 v17.3]